Not Medicare Enrolled

Dr. Tarek Aly, MD, MPH

Psychiatry · Daytona Beach, FL
Speaking/Promotional
3500 W INTERNATIONAL SPEEDWAY BLVD, Daytona Beach, FL 32124
4079063755
In practice since 2015 (10 years)
NPI: 1225419559 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Aly from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aly? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Aly

Dr. Tarek Aly is a psychiatry in Daytona Beach, FL, with 10 years in practice.

Between the years covered by Open Payments, Dr. Aly received a total of $73,262 from 22 pharmaceutical and/or device companies across 253 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Aly is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice$ $73,262 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$73,262
Total received (2020-2024)
Avg $14,652/year across 5 years
Top 3% in FL for psychiatry
22
Companies
253
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$71,339 (97.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,923 (2.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$19,510
2023
$26,726
2022
$9,305
2021
$17,659
2020
$63

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AbbVie Inc.
$31,404
ABBVIE INC.
$24,831
Neos Therapeutics, LP
$11,469
Aytu BioPharma, Inc.
$3,703
Corium, LLC
$352
Alkermes, Inc.
$317
Otsuka America Pharmaceutical, Inc.
$205
Lundbeck LLC
$180
Tris Pharma Inc
$142
Supernus Pharmaceuticals, Inc.
$127
Janssen Pharmaceuticals, Inc
$113
ITI, Inc.
$95
Almatica Pharma LLC
$61
IRONSHORE PHARMACEUTICALS INC.
$55
Noven Therapeutics, LLC
$37
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$34
Neurocrine Biosciences, Inc.
$33
Ironshore Pharmaceuticals Inc.
$33
Bausch Health US, LLC
$19
BioXcel Therapeutics, Inc.
$17
Corium, Inc.
$17
Takeda Pharmaceuticals U.S.A., Inc.
$15
Top 3 companies account for 92.4% of total payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · APLENZIN · ARISTADA · AZSTARYS · Adzenys XR-ODT · Azstarys · CAPLYTA · COTEMPLA XR-ODT · Cotempla XR-ODT · Dyanavel XR · IGALMI · INGREZZA · JORNAY PM · LOREEV XR · QELBREE · Qelbree · REXULTI · SPRAVATO · TRINTELLIX · VIVITROL · VRAYLAR · Vivitrol · Xelstrym · ZolpiMist
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in psychiatry and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for psychiatry in FL.

Looking for a psychiatry in Daytona Beach?
Compare psychiatrys in the Daytona Beach area by procedure volume, costs, and industry payment transparency.
Browse psychiatrys nearby

Geographic Context

Psychiatrys within 10 mi
39
Per 100K population
6.9
County median income
$66,581
Nearest hospital
HALIFAX HEALTH MEDICAL CENTER
7.1 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Aly is a psychiatry, and high industry engagement (speaking/promotional, top 3%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Aly receive payments from pharmaceutical companies?
Yes. Dr. Aly received a total of $73,262 from 22 companies across 253 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Aly) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →